Global PET Scanners Market – Imaging Innovations & Forecast 2026–2034

PET Scanners Market Size and Forecast 2026-2034

PET Scanners Market is expected to reach US$ 3.93 Billion by 2034 from US$ 2.83 Billion in 2025, with a CAGR of 3.73% from 2026 to 2034. Increasing cancer prevalence, growing demand for early disease detection, expanding adoption of precision medicine, advancements in hybrid imaging technologies, and rising investments in healthcare infrastructure are driving the PET scanners market. AI-enabled imaging and radiopharmaceutical innovations further support sustained market expansion.

PET Scanners Industry Overview

Positron Emission Tomography (PET) scanners are advanced diagnostic imaging systems that detect metabolic and physiological activity within the body using radioactive tracers. Frequently combined with computed tomography (PET/CT) or magnetic resonance imaging (PET/MRI), these systems provide highly detailed anatomical and functional images for accurate disease diagnosis. PET scanners are extensively used in oncology, cardiology, neurology, and research applications to identify cancer, monitor treatment response, evaluate heart function, and diagnose neurological disorders. Continuous improvements in detector technology, artificial intelligence, image reconstruction, and radiopharmaceutical development have enhanced imaging quality, reduced scan times, and increased diagnostic accuracy, making PET scanners an essential component of modern precision medicine.

The PET scanners market is experiencing significant growth due to increasing demand for early disease diagnosis, rising cancer incidence, and expanding use of molecular imaging in precision medicine. Hospitals and diagnostic centers are investing in advanced PET/CT and PET/MRI systems equipped with artificial intelligence and high-resolution imaging capabilities to improve clinical outcomes. Growing availability of novel radiopharmaceuticals is expanding clinical applications beyond oncology into neurology and cardiology. Government healthcare investments, favorable reimbursement policies in several countries, and continuous technological innovations are further accelerating market adoption. Increasing emphasis on personalized treatment planning and improved diagnostic efficiency continues to create long-term growth opportunities.

Recent Developments in PET Scanners Market

• June 2024: Researchers introduced Augmented Whole-Body Scanning via Magnifying PET (AWSM-PET), an advanced imaging technology that significantly improves image resolution and system sensitivity, enhancing the diagnostic performance of clinical whole-body PET/CT examinations.
• April 2024: CDL Nuclear Technologies launched its Mobile Dedicated Cardiac PET/CT Trailer, an innovative mobile imaging solution that delivers advanced cardiac PET/CT services directly to healthcare facilities on scheduled visits, improving accessibility and operational flexibility for cardiovascular diagnostics.

Growth Drivers for the PET Scanners Market

Technological Advancements in Total-Body PET Imaging

Continuous innovation in PET imaging technology is significantly improving diagnostic precision, scan speed, and workflow efficiency. Modern total-body PET/CT systems provide wider anatomical coverage, higher sensitivity, and lower radiation exposure, enabling clinicians to detect diseases at earlier stages while improving patient comfort. Artificial intelligence-powered image reconstruction further enhances image quality and reduces examination time. Healthcare providers are increasingly investing in these advanced imaging platforms to strengthen oncology, cardiology, and neurology services.

In November 2025, GE HealthCare received CE Mark approval for its Omni 128 cm total-body PET/CT system, expanding access to high-precision oncology imaging across Europe. The introduction of next-generation total-body imaging solutions demonstrates the industry's commitment to improving diagnostic performance while supporting precision medicine, making technological innovation a major growth driver for the global PET scanners market.

Expanding Availability of Advanced Radiopharmaceuticals

The growing availability of targeted radiopharmaceuticals is broadening the clinical applications of PET imaging and increasing demand for advanced PET scanners. Novel tracers enable clinicians to visualize specific biological processes, improving disease detection, staging, and treatment monitoring, particularly in oncology. The expansion of theranostics is further strengthening the integration of molecular imaging into personalized treatment pathways. Regulatory approvals for innovative diagnostic agents are encouraging healthcare providers to adopt PET imaging across a wider range of clinical settings.

In June 2025, Telix received authorization in Italy for Illuccix, its gallium-68 PSMA imaging agent, expanding access to advanced PET imaging for prostate cancer diagnosis. Such regulatory milestones increase the utilization of PET systems and support the continued growth of molecular imaging worldwide.

Increasing Healthcare Investments in AI-Enabled Diagnostic Imaging

Healthcare providers worldwide are investing in advanced diagnostic infrastructure to improve clinical accuracy and patient outcomes. AI-enabled PET/CT systems enhance workflow efficiency, automate image analysis, and support faster diagnosis, making them increasingly attractive for hospitals and diagnostic centers. Growing demand for pediatric imaging, oncology diagnostics, and precision medicine is accelerating investments in modern imaging technologies. Emerging economies are also expanding access to advanced molecular imaging through hospital modernization initiatives.

In June 2025, S L Raheja Hospital in Mumbai introduced an AI-enabled digital PET/CT system alongside a 3T MRI platform, strengthening advanced diagnostic capabilities, particularly for pediatric care. Such investments demonstrate the increasing adoption of intelligent imaging technologies that improve diagnostic quality and drive sustained growth in the global PET scanners market.

Challenges in the PET Scanners Market

High Equipment and Operational Costs

PET scanners require substantial capital investment, making adoption challenging for smaller hospitals and diagnostic centers. In addition to equipment costs, healthcare providers must invest in specialized infrastructure, radiopharmaceutical production or supply, maintenance, quality assurance, and highly trained personnel. The short half-life of many PET tracers also increases operational complexity by requiring nearby cyclotrons or reliable distribution networks. These financial and logistical requirements can limit technology adoption, particularly in developing regions with constrained healthcare budgets. Although technological advancements are improving efficiency, the high total cost of ownership remains a significant barrier to widespread deployment and market expansion.

Limited Access to Radiopharmaceuticals and Skilled Professionals

The availability of PET imaging depends heavily on reliable access to radiopharmaceuticals and experienced nuclear medicine professionals. Many regions continue to face shortages of tracer production facilities, specialized pharmacists, medical physicists, and trained imaging personnel. Supply chain disruptions affecting radioactive isotopes can delay patient diagnosis and reduce scanner utilization. Additionally, strict regulatory requirements governing the production, transportation, and handling of radioactive materials increase operational complexity. Limited workforce availability and infrastructure gaps restrict the expansion of PET imaging services, particularly in emerging healthcare markets. Addressing these challenges requires continued investment in workforce training, regional production facilities, and healthcare infrastructure.

United States PET Scanners Market

The United States dominates the PET scanners market due to its advanced healthcare infrastructure, widespread adoption of molecular imaging, favorable reimbursement environment, and high prevalence of cancer. Continuous investment in precision medicine and theranostics is driving demand for next-generation PET/CT systems across hospitals and imaging centers. In June 2024, Siemens Healthineers received U.S. FDA clearance for the Biograph Trinion PET/CT scanner, a high-performance system featuring ultra-fast time-of-flight technology, energy-efficient operation, and scalable design for oncology, cardiology, neurology, and theranostics. The launch strengthens access to advanced molecular imaging while supporting the country's leadership in diagnostic imaging innovation.

Germany PET Scanners Market

Germany is a leading European market for PET scanners, supported by its strong medical technology industry, advanced research institutions, and growing adoption of precision oncology. Hospitals continue investing in high-performance molecular imaging systems to improve diagnostic accuracy and personalized treatment planning. In December 2024, Siemens Healthineers introduced the Biograph One PET/MR system, combining PET and magnetic resonance imaging with AI-powered image reconstruction and simplified workflows to support theranostics and personalized healthcare. The innovative platform expands Germany's leadership in advanced imaging technologies while strengthening clinical capabilities across oncology, neurology, and research applications.

India PET Scanners Market

India's PET scanners market is expanding rapidly due to the rising burden of cancer, growing investments in advanced diagnostic imaging, and increasing adoption of precision medicine across multispecialty hospitals. Government initiatives to strengthen oncology infrastructure and the expansion of private diagnostic networks are accelerating demand for PET/CT systems nationwide. Healthcare providers are also integrating artificial intelligence to improve image quality, diagnostic accuracy, and workflow efficiency. In June 2025, S. L. Raheja Hospital in Mumbai launched an AI-enabled digital PET/CT system alongside a 3T MRI platform, significantly enhancing its molecular imaging capabilities for oncology and pediatric diagnostics. The introduction of advanced imaging technologies is expected to improve early disease detection, expand access to high-quality diagnostics, and support continued growth of India's PET scanners market.

Saudi Arabia PET Scanners Market

Saudi Arabia's PET scanners market is growing steadily due to rising investments in healthcare infrastructure, increasing cancer screening initiatives, and the government's focus on advanced diagnostic technologies under Vision 2030. Hospitals are expanding molecular imaging capabilities to improve early disease detection and precision medicine. In May 2025, the Saudi Ministry of Health introduced the first Ministry-operated PET-CT scanner in the western region at King Abdullah Medical City in Makkah. The advanced imaging system enhances diagnostic capabilities for cancer, cardiovascular, and neurological diseases while improving access to high-quality molecular imaging services for patients and pilgrims.

Full Ring PET Scanner Market

The Full Ring PET Scanner market is experiencing steady growth due to its superior imaging sensitivity, faster scan times, and improved diagnostic accuracy compared to partial-ring configurations. Full ring detector systems capture a greater number of emitted photons, enabling high-resolution images with lower radiation doses and shorter examination durations. These scanners are widely adopted for oncology, cardiology, neurology, and research applications where precise disease detection is critical. Continuous advancements in digital detector technology, artificial intelligence-based image reconstruction, and time-of-flight capabilities are further enhancing system performance. Hospitals and diagnostic imaging centers increasingly prefer full ring PET scanners to improve workflow efficiency and support precision medicine. Growing investments in advanced molecular imaging infrastructure continue to drive demand for this market segment globally.

PET-CT Market

The PET-CT market represents the largest segment within molecular imaging because it combines functional PET imaging with detailed anatomical information from computed tomography in a single examination. This integrated approach enables accurate disease detection, staging, treatment planning, and therapy monitoring across oncology, cardiology, neurology, and infectious disease applications. Healthcare providers increasingly prefer PET-CT systems due to their high diagnostic accuracy, reduced scanning time, and improved clinical workflow. Technological advancements, including digital detectors, artificial intelligence-assisted image reconstruction, total-body PET-CT systems, and enhanced radiopharmaceuticals, continue improving imaging performance. Rising cancer prevalence, expanding precision medicine initiatives, and growing investments in diagnostic infrastructure are expected to sustain strong growth in the global PET-CT market.

Oncology PET Scanners Market

The oncology PET scanners market accounts for the largest share of the PET imaging industry because molecular imaging plays a vital role in cancer diagnosis, staging, treatment planning, and therapy response assessment. PET scanners enable clinicians to detect tumors at early stages by identifying abnormal metabolic activity before structural changes become visible through conventional imaging. Increasing global cancer incidence, expanding adoption of targeted therapies, and growing demand for precision oncology are driving market growth. The development of novel radiopharmaceuticals, including PSMA and other cancer-specific tracers, is broadening clinical applications. Continuous advancements in digital PET technology, artificial intelligence, and total-body imaging systems further improve diagnostic accuracy, supporting greater adoption across hospitals and specialized cancer centers worldwide.

Hospitals Market

Hospitals represent the leading end-user segment in the PET scanners market due to their comprehensive diagnostic capabilities, specialized clinical expertise, and ability to manage complex imaging procedures. Large hospitals continue investing in advanced PET/CT and PET/MRI systems to strengthen oncology, cardiology, neurology, and precision medicine services. The availability of multidisciplinary medical teams, nuclear medicine specialists, and integrated treatment facilities supports efficient diagnosis and personalized patient care. Increasing patient volumes, rising cancer screening programs, and expanding hospital infrastructure are further driving demand for advanced molecular imaging equipment. Additionally, hospitals are increasingly adopting AI-enabled imaging technologies and digital workflow solutions to improve operational efficiency, diagnostic accuracy, and overall patient outcomes, reinforcing their dominant position in the PET scanners market.

Research Methodology of PET Scanners Market

The PET Scanners Market was estimated using a combination of bottom-up and top-down approaches, secondary research, installed-base analysis, scanner shipment assessment, replacement-cycle analysis, company-level revenue validation, and data triangulation. The methodology considered PET-only scanners and PET systems incorporated into hybrid imaging platforms such as PET/CT and PET/MRI, depending on the defined market scope.

1. Market Definition and Scope

The market was first defined to determine the products and revenues included in the assessment.

The PET Scanners Market was considered to include revenue generated from the sale and installation of positron emission tomography imaging systems used for diagnostic and clinical applications.

2. Secondary Research

Extensive secondary research was conducted to establish the fundamental market variables.

Information was collected from:

• Government healthcare agencies
• Nuclear medicine associations
• Radiology organizations
• Hospital databases
• Medical imaging associations
• PET scanner manufacturers
• Healthcare providers
• Diagnostic imaging centers
• Company annual reports
• Investor presentations, etc.

The research focused on:

• PET scanner installations
• Annual system shipments
• Existing installed base
• Scanner pricing
• Replacement demand
• Hospital procurement
• Imaging-center expansion
• PET/CT and PET/MRI adoption
• Technology upgrades

3. Bottom-Up Market Estimation

A bottom-up approach was used as the primary market-sizing methodology.

The market was estimated by determining the number of PET scanners sold or installed and multiplying this volume by the average selling price.

The basic calculation was:

Number of PET Scanners Sold × Average Selling Price per Scanner = PET Scanner Market Revenue

The calculation was performed separately and the individual segment values were subsequently aggregated to determine the total market.

4. Scanner Shipment Estimation

Annual scanner shipments were estimated using manufacturer disclosures, healthcare procurement records, hospital installations, distributor information, and industry interviews.

The analysis considered:

• New hospital installations
• New diagnostic-center installations
• Replacement systems
• Expansion of existing imaging departments
• Research installations
• Government healthcare projects

Where shipment data were unavailable, scanner installations were estimated from the number of healthcare facilities and the average number of PET systems purchased annually.

5. Installed-Base Analysis

The installed base was estimated to determine replacement demand.

Historical PET scanner installations were accumulated and adjusted for:

• Scanner retirement
• Equipment replacement
• Decommissioning
• Technology upgrades
• Hospital closures
• Facility expansion
• Equipment relocation

The calculation was:

Historical PET Scanner Installations − Retired Systems = Active PET Scanner Installed Base

The installed base provided the foundation for calculating the replacement market.

6. Replacement Market Estimation

PET scanner replacement demand was estimated by applying an average equipment replacement cycle to the installed base.

The calculation was:

Installed PET Scanner Base × Annual Replacement Rate × Average Scanner Price = Replacement Market

Replacement assumptions were differentiated according to:

• Scanner age
• Technology generation
• Hospital type
• System utilization
• Technological obsolescence
• Availability of advanced imaging capabilities

Digital PET and hybrid systems were separately considered because their replacement patterns could differ from older-generation PET systems.

7. New Installation Market

New-installation demand was calculated separately from replacement demand.

The analysis considered:

• New hospitals
• New cancer centers
• New diagnostic imaging centers
• Expansion of nuclear medicine departments
• Increasing PET imaging capacity
• Government healthcare projects
• Research institutions

The calculation was:

New PET Installations × Average Selling Price = New Equipment Revenue

The new-installation and replacement estimates were then combined.

8. PET/CT Market Estimation

PET/CT systems were assessed separately because they represented an important hybrid imaging category.

The analysis considered:

• Number of PET/CT installations
• CT configuration
• Detector technology
• Digital versus analog PET
• Clinical application
• Average system price

The calculation was:

PET/CT Systems Sold × Average PET/CT Selling Price = PET/CT Market Revenue

PET/CT systems were not counted again under standalone PET systems to prevent double counting.

9. PET/MRI Market Estimation

PET/MRI systems were separately assessed because they had different pricing, installation requirements, and applications.

The analysis considered:

• PET/MRI installations
• Hospital and research demand
• Neurology applications
• Oncology applications
• System pricing
• Replacement requirements

The calculation was:

PET/MRI Systems Sold × Average PET/MRI Selling Price = PET/MRI Market Revenue

10. Average Selling Price Estimation

Average selling prices were estimated separately for each PET scanner category.

Pricing information was obtained from:

• Manufacturer product information
• Hospital procurement documents
• Distributor quotations
• Public tenders
• Industry interviews
• Healthcare equipment suppliers
• Company disclosures

Prices were adjusted based on:

• Scanner configuration
• Detector technology
• Number of imaging slices for integrated CT systems
• Digital versus analog technology
• Software
• Installation
• Service agreements
• Additional accessories

Where bundled contracts were identified, the scanner hardware component was separated from service and maintenance revenue when required by the market definition.

11. End-User Analysis

Demand was assessed across different end users.

Hospitals

Hospital PET demand was estimated based on:

• Number of hospitals with nuclear medicine departments
• Existing PET capacity
• Patient volumes
• Replacement requirements
• New facility development

Diagnostic Imaging Centers

The analysis considered:

• Number of imaging centers
• PET imaging availability
• Patient throughput
• New installations
• Replacement demand

Research and Academic Institutions

Research demand was estimated separately based on:

• Number of research institutions
• PET research programs
• Clinical research
• Pharmaceutical research
• Neuroscience applications

12. Company-Level Revenue Analysis

Major PET scanner manufacturers were identified and analyzed.

Company annual reports, investor presentations, product portfolios, regional sales, and equipment revenue were reviewed.

Where companies generated revenue from several imaging modalities, the PET-related portion was isolated or estimated.

13. Top-Down Market Estimation

A top-down approach was applied to independently validate the bottom-up estimate.

The broader nuclear medicine and medical imaging equipment markets were assessed, followed by an estimate of the share attributable to PET scanners.

The calculation was structured as:

Relevant Medical Imaging/Nuclear Medicine Equipment Market × PET Scanner Share = Estimated PET Scanner Market

The PET share was determined using:

• Number of PET installations
• PET imaging utilization
• Healthcare facility adoption
• PET/CT penetration
• PET/MRI penetration
• Equipment expenditure

The top-down result was compared with the bottom-up estimate.

14. Supply-Side Validation

The supply side was analyzed by examining manufacturers and distributors.

The assessment considered:

• PET scanner revenues
• Regional sales
• Production capacity
• Distribution networks
• Installed systems
• Product portfolios
• New product launches

The estimated supplier-side revenue was compared with the demand-side market calculation.

15. Demand-Side Validation

Demand was validated using healthcare facility and procedure information.

The calculation followed:

Healthcare Facilities → PET-Eligible Facilities → Installed PET Systems → New Purchases/Replacement → Market Revenue

PET scan volumes and patient demand were used as supporting indicators of equipment requirements.

High-utilization facilities were assessed separately where appropriate because they could require additional systems or faster replacement cycles.

16. Procurement and Tender Analysis

Hospital and government procurement activities were reviewed where information was publicly available.

The assessment considered:

• Equipment tenders
• Hospital procurement contracts
• Government healthcare projects
• Diagnostic-center expansions
• Nuclear medicine department upgrades

Procurement values were used to validate average system prices and installation volumes.

17. Installation and Service Revenue Treatment

The market definition was reviewed to determine whether installation, software, and service contracts were included.

Where the market was defined as PET scanner equipment revenue, the calculation primarily included scanner hardware and directly associated equipment.

Maintenance contracts, radiopharmaceuticals, PET imaging services, and unrelated nuclear medicine products were excluded unless explicitly included in the defined market scope.

This helped maintain consistency and avoid double counting.

18. Forecast Estimation

The historical market base was used to develop the forecast.

Future demand was assessed based on:

• Growth in cancer diagnosis
• Increasing PET imaging utilization
• Expansion of nuclear medicine departments
• Replacement of aging scanners
• Adoption of digital PET
• Expansion of PET/CT
• Development of PET/MRI
• Increasing demand for advanced imaging
• Expansion of healthcare infrastructure
• Technological improvements in PET imaging

Separate growth assumptions were applied to new installations and replacement demand.

19. Data Triangulation

The final PET Scanner Market estimate was established through three principal approaches:

Bottom-Up Approach

PET Scanner Shipments × Average Selling Price

Top-Down Approach

Relevant Nuclear Medicine/Medical Imaging Equipment Market × PET Share

Supply-Side Approach

Manufacturer Revenue + Procurement Data + Installed Base

The three estimates were compared and reconciled.

Where discrepancies occurred, assumptions relating to scanner shipments, installed base, replacement rates, pricing, and technology adoption were reassessed.

20. Final Market Calculation

The final estimate was then validated against scanner shipments, installed-base calculations, replacement demand, manufacturer revenues, hospital procurement data, average selling prices and top-down estimates.

PET Scanners Market Segments:

Product Type

• Full Ring PET Scanner
• Partial Ring PET Scanner

Modality

• PET-CT
• PET-MRI

Application

• Oncology
• Cardiology
• Neurology
• Others

End Use

• Hospitals
• Diagnostic Imaging Centers
• Academic & Research Institutes

Countries

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All the Key players have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Canon Medical Systems
• GE Healthcare
• Kindsway Biotech
• Koninklijke Phillips N.V.
• Mediso Ltd.
• PerkinElmer
• Positron
• Shimadzu Corporation
• Siemens Healthineers AG

Report Details: